The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations
Open accessAbstract
The emergence of multidrug-resistant strains of Mycobacterium tuberculosis has resulted in increased interest in the fluoroquinolones (FQs) as antituberculosis agents. To investigate the frequency and mechanisms of FQ resistance in M. tuberculosis, we cloned and sequenced the wild-type gyrA and gyrB genes, which encode the A and B subunits of the DNA gyrase, respectively; DNA gyrase is the main target of the FQs. On the basis of the sequence information, we performed DNA amplification for sequencing and single-strand conformation polymorphism analysis to examine the presumed quinolone resistance regions of gyrA and gyrB from reference strains (n = 4) and clinical isolates (n = 55). Mutations in codons of gyrA analogous to those described in other FQ-resistant bacteria were identified in all isolates (n = 14) for which the ciprofloxacin MIC was > 2 micrograms/ml. In addition, we selected ciprofloxacin-resistant mutants of Mycobacterium bovis BCG and M. tuberculosis Erdman and H37ra. Spontaneously resistant mutants developed at a frequency of 1 in 10(7) to 10(8) at ciprofloxacin concentrations of 2 micrograms/ml, but no primary resistant colonies were selected at higher ciprofloxacin concentrations. Replating of those first-step mutants selected for mutants with high levels of resistance which harbored gyrA mutations similar to those found among clinical FQ-resistant isolates. The gyrA and gyrB sequence information will facilitate analysis of the mechanisms of resistance to drugs which target the gyrase and the implementation of rapid strategies for the estimation of FQ susceptibility in clinical M. tuberculosis isolates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
van Embden, J. D., Cave, M. D., Crawford, J. T., Dale, J. W., Eisenach, K. D., Gicquel, B., Hermans, P., Martin, C., McAdam, R., & Shinnick, T. M. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.2.406-409.1993 · Cited by 2,342
Telenti, A., Marchesi, F., Balz, M., Bally, F., Böttger, E. C., & Bodmer, T. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.2.175-178.1993 · Cited by 1,498
Self-citationDetection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
Self-citationQuinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
New topoisomerase essential for chromosome segregation in E. coli
Kato, J.-I., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S., & Suzuki, H. (1990) · Cell · doi:10.1016/0092-8674(90)90172-b · Cited by 566
[25] Genetic systems for mycobacteria
Jacobs, W. R., Kalpana, G. V., Cirillo, J. D., Pascopella, L., Snapper, S. B., Udani, R. A., Jones, W., Barletta, R. G., & Bloom, B. R. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)04027-l · Cited by 433
Self-citationWang, Y., Huang, W. M., & Taylor, D. E. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.457 · Cited by 280
Self-citationDiscovery and development of new antibiotics: the problem of antibiotic resistance
Silver, L. L., & Bostian, K. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.377 · Cited by 253
Telenti, A., Imboden, P., Marchesi, F., Schmidheini, T., & Bodmer, T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2054 · Cited by 250
Self-citationFischl, M. A., Daikos, G. L., Uttamchandani, R. B., Poblete, R. B., Moreno, J. N., Reyes, R. R., Boota, A. M., Thompson, L. M., Cleary, T. J., Oldham, S. A., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-184 · Cited by 248
Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis
Siddiqi, S. H., Libonati, J. P., & Middlebrook, G. (1981) · Journal of Clinical Microbiology · doi:10.1128/jcm.13.5.908-912.1981 · Cited by 242
Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12
Hirai, K., Aoyama, H., Suzue, S., Irikura, T., Iyobe, S., & Mitsuhashi, S. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.2.248 · Cited by 192
Sreedharan, S., Oram, M., Jensen, B., Peterson, L. R., & Fisher, L. M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.12.7260-7262.1990 · Cited by 173
Davis, E. O., Sedgwick, S. G., & Colston, M. J. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.18.5653-5662.1991 · Cited by 152
Confreres, A., & Maxwell, A. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb00886.x · Cited by 111
Bacterial Resistance to Quinolones: Mechanisms and Clinical Importance
Wolfson, J. S., & Hooper, D. C. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_5.s960 · Cited by 107
Barry, A. L., & Jones, R. N. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.6.775 · Cited by 89
Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice
Lalande, V., Truffot-Pernot, C., Paccaly-Moulin, A., Grosset, J. H. E., & Ji, B. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.407 · Cited by 88
In-vitro selection of bacteria resistant to the 4-quinolone agents
Limb, D. I., Dabbs, D. J. W., & Spencer, R. C. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/19.1.65 · Cited by 39
Chen, C.-H., Shih, J.-F., Lindholm-Levy, P. J., & Heifets, L. B. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.4.987 · Cited by 34
Cited by
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Self-citationThe Continuing Challenges of Leprosy
Scollard, D. M., Adams, L. B., Gillis, T. P., Krahenbuhl, J. L., Truman, R. W., & Williams, D. L. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.338-381.2006 · Cited by 928
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Metadata
- Authors
- Takiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B., Cole, S. T., Jacobs, W. R., & Telenti, A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1994-04
- Volume
- 38
- Issue
- 4
- Pages
- 773-780
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2129759335
- Cited by
- 480
- References
- 20
- FWCI
- 23.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.